- [1] 赵伟. TOB1 attenuates IRF3-directed antiviral responses by recruiting HDAC8 to specifically suppress IF.... COMMUNICATIONS BIOLOGY, 943, 2022.
- [2] 李琪. KAP1-Mediated Epigenetic Suppression in Anti-RNA Viral Responses by Direct Targeting RIG-I and MD.... J Immunol , 207, 2021.
- [3] 贾秀芝. Emerging Roles of MHC Class I Region-Encoded E3 Ubiquitin Ligases in Innate Immunity. Frontiers in Immunology, 12, 2021.
- [4] 王雯雯. Galectin-9 Targets NLRP3 for Autophagic Degradation to Limit Inflammation. Journal of Immunology, 206, 2692, 2021.
- [5] 秦颖. TRIM28 SUMOylates and stabilizes NLRP3 to facilitate inflammasome activation. Nature Communications, 12, 2021.
- [6] 张锦涛. Virus Caused Imbalance of Type I IFN Responses and Inflammation in COVID-19. Frontiers in Immunology, 12, 2021.
- [7] 贾木天. Redox homeostasis maintained by GPX4 facilitates STING activation. Nature Immunology, 21, 727, 2020.
- [8] 宋慧. UAF1 deubiquitinase complexes facilitate NLRP3 inflammasome activation by promoting NLRP3 express.... Nature Communications, 11, 2020.
- [9] 王雯雯. RNF39 mediates K48-linked ubiquitination of DDX3X and inhibits RLR-dependent antiviral immunity. 科学前沿, 7, 2021.
- [10] 赵伟 and 赵春媛. NLRP3 Inflammasome-A Key Player in Antiviral Responses. Frontiers in Immunology, 11, 2020.
- [11] 赵伟 and 赵春媛. TANK-binding kinase 1 as a novel therapeutic target for viral diseases. EXPERT OPINION ON THERAPEUTIC TARGETS, 23, 437, 2019.
- [12] 张利宁 , 赵伟 and 赵春媛. The E3 Ubiquitin Ligase TRIM40 Attenuates Antiviral Immune Responses by Targeting MDA5 and RIG-I. cell reports, 21, 1613, 2017.
|